ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials in Baden, Aargau

Find clinical trials in Baden, Aargau. Discover local research opportunities and treatment options in your area.

14 Active Trials Found in Baden

Showing 14 trials on this page

Page 1 of 1

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

NCT ID: NCT06140836

The TRIDENT-3 clinical trial is studying two medications, repotrectinib and crizotinib, to see how effective and safe they are for treating patients with a specific type of lung cancer called ROS1-...

Recruiting
Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

NCT ID: NCT06717347

This clinical trial is studying a new treatment for patients with diffuse large B-cell lymphoma (DLBCL), a type of cancer that affects the lymphatic system. Researchers want to see if adding a drug...

Recruiting
Phase: PHASE3 Conditions: Diffuse Large B-Cell Lymphoma

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

NCT ID: NCT07100080

This clinical trial is studying a new drug called Izalontamab Brengitecan to see how well it works compared to a standard chemotherapy treatment (platinum-pemetrexed) for people with a specific typ...

Not yet recruiting
Phase: PHASE2 Conditions: Non-Small Cell Lung Cancer

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT04928846

This clinical trial is studying a new treatment called telisotuzumab vedotin for adults with non-small cell lung cancer (NSCLC) who have already received treatment in the past. Researchers want to ...

Recruiting
Phase: PHASE3 Conditions: Non Small Cell Lung Cancer

A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT ID: NCT06052306

This clinical trial is studying a new treatment called actinium-225-macropa-pelgifatamab (also known as BAY3546828) for men with advanced metastatic castration-resistant prostate cancer (mCRPC), wh...

Recruiting
Phase: PHASE1 Conditions: Metastatic Castration-resistant Prostate Cancer

A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT ID: NCT06452277

This clinical trial is studying a new treatment called BAY 2927088 for people with advanced non-small cell lung cancer (NSCLC) that has specific gene changes known as HER2 mutations. The goal is to...

Recruiting
Phase: PHASE3 Conditions: Advanced Non-small Cell Lung Cancer, HER2 Mutation

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

NCT ID: NCT06091254

This clinical trial is studying a new experimental drug called odronextamab to see if it is safe and effective for people with follicular lymphoma, a type of blood cancer. The trial has two parts: ...

Recruiting
Phase: PHASE3 Conditions: Follicular Lymphoma (FL)

The MOBY Study: Efficacy of Birth Mobility

NCT ID: NCT07052331

This clinical trial, called the MOBY Study, is looking at how moving around during labor affects the birth experience and outcomes for first-time mothers. The researchers want to find out if using ...

Not yet recruiting
Phase: NA Conditions: Healthy, Cesarean Section Rate +2 more

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

NCT ID: NCT05382299

This clinical trial is studying a new treatment called sacituzumab govitecan-hziy (SG) for patients with locally advanced or metastatic triple-negative breast cancer (TNBC) that has not been treate...

Recruiting
Phase: PHASE3 Conditions: Triple Negative Breast Cancer, PD-L1 Negative

OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy

NCT ID: NCT06466382

The OV Precision trial is a research study aimed at finding out if patients with certain types of ovarian cancer can benefit from a personalized cancer therapy that takes into account specific info...

Recruiting
Phase: NA Conditions: Fallopian Tube Neoplasms, Ovarian Neoplasm Epithelial +2 more

Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty

NCT ID: NCT05993845

This clinical trial is studying a specific type of hip surgery called total hip arthroplasty (THA), using a technique known as the direct anterior approach (DAA). The goal is to create a detailed g...

Recruiting
Conditions: Hip Prosthesis

Shivering_Basel_Baden

NCT ID: NCT04938219

The Shivering_Basel_Baden clinical trial is studying a new way to help women who experience shivering during a cesarean section, which can happen in about 40% of cases when certain types of anesthe...

Recruiting
Phase: NA Conditions: Shivering

Role of Microbiome in BCG Responsiveness Prediction

NCT ID: NCT05204199

This clinical trial is looking at how the bacteria in the bladder and gut can help predict how well patients with a type of bladder cancer called NMIBC will respond to a treatment called BCG. Resea...

Recruiting
Conditions: Bladder Cancer, Microbiome

The SwissPrEPared Study

NCT ID: NCT03893188

The SwissPrEPared Study is a research project designed to follow individuals who are interested in taking Pre-exposure Prophylaxis (PrEP) to prevent HIV. This study is part of a larger program and ...

Recruiting
Conditions: HIV Preexposure Prophylaxis
Search All Trials Browse All Locations